ThermiGen, LLC Announces New Branding Platform and Name Change to Reflect Company’s Expansion and Restructuring

Share Article

Company’s New Name, ThermiHealth, More Accurately Defines Widening Use of Technology to Address Broad List of Health Concerns

The name change to ThermiHealth represents our continued development and exploration of the uses of thermistor regulated energy delivery platforms for both aesthetic and clinical applications.

ThermiGen, LLC, dba, ThermiAesthetics, a privately held company that develops thermistor controlled radio frequency technologies for applications in the medical and aesthetic marketplace, today announces a name change from ThermiGen, LLC to ThermiHealth.

“The name change to ThermiHealth represents our continued development and exploration of the uses of thermistor regulated energy delivery platforms for both aesthetic and clinical applications,” says Paul Herchman, CEO of ThermiHealth.

The ThermiHealth family of companies include ThermiAesthetics, a division of ThermiHealth, and two new wholly owned subsidiaries, ThermiGyn and ThermiEye. “The new structure marks the emergence of our broad appeal to large number specialties and our increasing portfolio of procedures to include ThermiTight, ThermiSmooth, ThermiDry, ThermiRase, and now ThermiVa and ThermiEye,” Herchman adds. “Our technology platform, with its predictable application of controlled heat to targeted tissue and precise tissue heat monitoring, is fast becoming the recognized standard of care. We expect to announce additional innovative solutions to healthcare needs in the coming year.”

“We’re very excited that the combination of thermistor regulated and the simultaneous monitoring of dermal subdermal and dermal tissues is being proven to be safe and effective in the treatment of not only skin laxity, but also vaginal tightening, dry eye and excessive sweating,” says Brian Kinney, MD, chair of the Clinical Advisory Board for ThermiHealth. “As we continue to explore the technologies’ applications, we believe we will discover many more effective uses for it.”

The Executive Team is composed of Paul Herchman, CEO; Kevin O’Brien, President and COO; and Mike McDonald, CFO. Brian Kinney, MD, FACS, MSME, chairs the Aesthetic Clinical Advisory Board; Red Alinsod, MD, FACOG, FACS, chairs the Women’s Health Advisory Board and David Meadows, PhD, chairs the Eye Health Advisory Board.

The website will remain http://www.thermi.com.

ThermiHealth Technology
ThermiHealth systems integrate precise thermistor controlled micro-invasive and non-invasive applicators into unique multiuse platforms. The micro-invasive applicators are true surgeons’ tools that, when combined with the FLIR Infrared Camera, provide surgeons a safe and effective instrument. Both the micro-invasive and the non-invasive applicators help the operator insure that specific tissue temperatures are achieved, maintained and monitored during procedures to help ensure safety and maximize results.

The ThermiAesthetics flagship product is the ThermiRF Temperature Controlled Radio Frequency Generator System and is FDA cleared for dermatological and general surgical procedures for electrocoagulation and hemostasis, and to create lesions in nervous tissue.

About ThermiHealth
ThermiHealth is a privately held company developing a broad range of uses for thermistor controlled radio frequency technologies and for applications in the medical and aesthetic marketplaces.

ThermiAesthetics, a Division of ThermiHealth, provides a number of advanced Thermi technology platforms using finely controlled thermal energy. The multi-use platform promotes increased patient safety and clinical effectiveness, while providing versatile micro-invasive and non-invasive solutions for plastic surgeons, facial plastic surgeons, dermatologists, cosmetic surgeons and other physicians serving the aesthetic market.

ThermiGyn, a wholly owned subsidiary of ThermiHealth, provides advanced technology using finely controlled thermal energy. The multi-use platform promotes increased patient safety and clinical effectiveness for treatments like that of vaginal laxity using ThermiVa, while providing versatile micro-invasive and non-invasive solutions for OB/GYNs serving the women’s health marketplace.

ThermiEye, a wholly owned subsidiary of ThermiHealth, provides advanced technology using finely controlled thermal energy to treat dry eyes. The multi-use platform promotes increased patient safety and clinical effectiveness, while providing versatile micro-invasive and non-invasive solutions for ophthalmologists, ocular plastic surgeons and other physicians serving the aesthetic market.

For more information about ThermiHealth companies, please visit http://www.thermi.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Emily Tidswell
Follow us on
Visit website